Market Research Report
North America Extra Corporeal Membrane Oxygenation (Ecmo) System Market Forecast 2019-2028
|Published by||Inkwood Research||Product code||953131|
|Published||Content info||114 Pages
Delivery time: 2-3 business days
|North America Extra Corporeal Membrane Oxygenation (Ecmo) System Market Forecast 2019-2028|
|Published: August 10, 2020||Content info: 114 Pages||
The North America extra corporeal membrane oxygenation (ECMO) system market is projected to register a CAGR of 4.78% during the projected period, 2019-2028. The high prevalence of respiratory diseases is the key factor influencing the growth of the market.
The North America extra corporeal membrane oxygenation (ECMO) system market growth analysis involves the evaluation of the United States and Canada. One of the major public health concerns in Canada is asthma. It affects the quality of life, productivity, psychological wellbeing, etc. of the population. According to the Canada 2019 annual asthma survey report, more than 3 million individuals had asthma in 2019. ECMO (extra corporeal membrane oxygenation) can supply adequate gas exchange during acute respiratory failure. Hence, the market is slated to grow steadily in the coming years. According to the National Clinical Trials Registry (NCT), the researchers from British Columbia are actively putting efforts to triple the survival rate of cardiac arrests. This is being done through the implementation of extracorporeal membrane oxygenation (ECMO)-CPR treatment. It has considerably reduced deaths in transplant waitlist patients. This has propelled the number of successful transplantations in Canada. Clinical professionals recognize ECMO as an efficient therapy. This, coupled with initiatives to increase acceptance, is set to influence the growth of the market in Canada.
Some of the major companies operating in the market include, Medtronic Plc, Microport Scientific Corporation Nipro Corporation, Spectrum Medical, Origen Biomedical Inc, etc.